Moexipril and Icatibant: Interaction Details
- Moexipril
- Univasc
- Icatibant
- FirazyrSajazir
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Moexipril and Icatibant interaction:
What Happens When You Take Moexipril With Icatibant
What can happen when they are taken together (rated Moderate)
Reduced moexipril effectiveness
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When icatibant is given together with an (for example, moexipril), the blood pressure lowering effect of the ACE inhibitor may be reduced, because icatibant antagonizes the bradykinin B2 receptor.1 In a clinical trial (n=27), captopril, an ACE inhibitor, produced a maximum fall in mean arterial blood pressure of -14 +/- 1 mmHg, whereas captopril combined with icatibant produced a maximum fall of -10.5 +/- 1 mmHg (p less than 0.001).2 Monitoring for inadequate blood pressure control may be considered when icatibant is coadministered with moexipril.
The Moexipril and Icatibant Interaction, Explained
Moexipril lowers your blood pressure, and part of how work involves a natural substance in your body called bradykinin. Icatibant (used to treat attacks of hereditary angioedema) blocks the receptor that bradykinin acts on. Because of this, icatibant may make moexipril work a little less well at lowering blood pressure.
This is mostly a theoretical concern, based on a small study using a related drug, captopril. Icatibant is usually given only during an attack, so the effect is likely short-lived. Keep taking both as prescribed, and let your pharmacist or doctor know you use both. They may check your blood pressure more closely.
Mechanism: Icatibant is a competitive bradykinin B2 receptor . Part of the hypotensive effect of comes from reduced bradykinin breakdown, so B2 blockade may attenuate moexipril's antihypertensive effect ( , not a PK interaction).
- Evidence: Theoretical. Supporting data come from a clinical trial (n=27) with captopril: maximum fall in MAP was -14 +/- 1 mmHg with captopril alone vs -10.5 +/- 1 mmHg with captopril plus icatibant (p<0.001).
- Onset: Unspecified. Icatibant is typically episodic, so any effect is likely transient.
- Management: Consider monitoring for loss of blood pressure control when icatibant is coadministered. Individualize therapy as needed.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Moexipril and Icatibant Interact
The likely mechanism
of bradykinin B2 receptors by icatibant
How to Manage the Moexipril and Icatibant Interaction
Your care team can manage this, and no change is usually needed on your own.
- Keep taking moexipril and icatibant exactly as prescribed.
- Your team may monitor your blood pressure more closely when you use icatibant.
- If your readings run higher than usual after an icatibant dose, tell your pharmacist or prescriber so they can tailor your treatment if needed.
- Do not stop or change either medicine without talking with your care team first.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Moexipril or Icatibant need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects
A single-blind, randomized, crossover study found that captopril, an , lowered mean arterial blood pressure slightly more than captopril given together with icatibant. All participants (n=27) received 4 treatments in random order, separated by 2-day intervals: captopril 25 mg orally plus IV NS, captopril 25 mg orally plus icatibant 100 mcg/kg IV, losartan 75 mg orally plus IV NS, and oral placebo plus IV NS. The largest decrease in mean arterial blood pressure was -14 +/- 1 mmHg after captopril, versus -10.5 +/- 1 mmHg after captopril plus icatibant (p=0.001).2
Moexipril and Icatibant: Common Questions
How serious is the Moexipril and Icatibant interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Moexipril and Icatibant interaction managed?
Your care team can manage this, and no change is usually needed on your own. Keep taking moexipril and icatibant exactly as prescribed. Your team may monitor your blood pressure more closely when you use icatibant. If your readings run higher than usual after an icatibant dose, tell your pharmacist or prescriber so they can tailor your treatment if needed. Do not stop or change either medicine wit… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Moexipril and Icatibant Interaction
Ask in your own words about taking Moexipril and Icatibant together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: FIRAZYR(R) subcutaneous injection solution, icatibant subcutaneous injection solution. Shire Orphan Therapies (per Manufacturer), Lexington, MA, 2011. DailyMed
- Gainer JV, Morrow JD, Loveland A, et al: Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 1998; 339(18):1285-1292. PubMed
Other Serious Interactions of Moexipril and Icatibant
Also serious with Moexipril
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Moexipril
- GrapefruitMajor
- Activated CharcoalMajor
- American HelleboreMajor
- American MistletoeMajor
- ArsenicMajor
- AsarabaccaMajor
- CesiumMajor
- EphedraMajor
- + 169 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.